George Yancopoulos - Apr 29, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Bd. Co-Chair, President & CSO, Director
Signature
/s/**George D. Yancopoulos
Stock symbol
REGN
Transactions as of
Apr 29, 2024
Transactions value $
$0
Form type
4
Date filed
5/1/2024, 04:03 PM
Previous filing
Feb 20, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -36.3K -100% $0.00* 0 Apr 29, 2024 by 2022 GRAT I
transaction REGN Common Stock Gift $0 +18.1K $0.00 18.1K Apr 29, 2024 by Children
holding REGN Common Stock 886K Apr 29, 2024 Direct
holding REGN Common Stock 5.9K Apr 29, 2024 By 401(k) Plan
holding REGN Common Stock 180K Apr 29, 2024 By Trust for Chldn. F1
holding REGN Common Stock 158K Apr 29, 2024 by 2022 GRAT II
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As investment trustee of trusts for the benefit of the reporting person's children.